Westone takeover ready for approval

Fledgling Dublin first-aid product developer Alltracel Pharmaceuticals has published the necessary listing document to allow its proposed takeover of dental care product manufacturer Westone.

Trading in the company’s shares, which was suspended earlier this week pending publication of the document, resumed on London’s Alternative Investment Market as a result.

The company will hold an extraordinary general meeting on January 13 to approve the deal, which will cost the company up to €8 million over the next two years.